Pursuant to SEBI Circular No. SEBI/HO /CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31,2024, read with BSE Circular No. 20250102-4 and NSE Circular No.: NSE/CML/2025/02, we are submitting herewith the Integrated Filing (Financial) for the quarter and Twelve Months ended March 31,2025.
TIJARIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tijaria Polypipes has reported audited results for FY25 showing a net loss of Rs. 543.01 lacs, almost double the Rs. 291.64 lacs loss in FY24, with quarterly loss of Rs. 314.44 lacs. Total income for the year was a meagre Rs. 33.74 lacs and there was no production in the Pipe segment during Q4. The company's total equity is deeply negative at Rs. (3,250.25) lacs due to accumulated losses of Rs. 11,989.89 lacs. The auditor (Amit Ramakant & Co.) issued a Disclaimer of Opinion citing multiple issues including Bank of India NPA status since 2022 on Rs. 71.73 crores of dues, unconfirmed receivables of Rs. 25.17 crores, unexplained increase in loans & advances by Rs. 5 crores, and an impairment loss of Rs. 3.12 crores on textile plant & machinery (original cost Rs. 66.28 crores). The company is attempting a One Time Settlement (OTS) with the bank using a fresh Rs. 5 crore loan from directors.
This filing paints a picture of severe financial distress — negative net worth, NPA-tagged loans, near-zero operations, and an auditor disclaimer are all serious red flags. Shareholders should brace for likely further dilution from the bank-led OTS process, continued losses, and significant risk of share value erosion or delisting action.